Table of Contents
ISRN Gastroenterology
Volume 2013, Article ID 935295, 8 pages
http://dx.doi.org/10.1155/2013/935295
Review Article

Hepatitis B Surface Antigen Could Contribute to the Immunopathogenesis of Hepatitis B Virus Infection

Division of Gastroenterology, Tohoku University Hospital, 1-1 Seiryo-Machi, Aoba-ku, Miyagi, Sendai City 980-8574, Japan

Received 11 November 2012; Accepted 24 December 2012

Academic Editors: G.-T. Huang, A. J. Karayiannakis, J. M. Kim, and A. A. te Velde

Copyright © 2013 Yasuteru Kondo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Tiollais, C. Pourcel, and A. Dejean, “The hepatitis B virus,” Nature, vol. 317, no. 6037, pp. 489–495, 1985. View at Google Scholar · View at Scopus
  2. C. L. Lai, V. Ratziu, M. F. Yuen, and T. Poynard, “Viral hepatitis B,” The Lancet, vol. 362, no. 9401, pp. 2089–2094, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Summers and W. S. Mason, “Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate,” Cell, vol. 29, no. 2, pp. 403–415, 1982. View at Google Scholar · View at Scopus
  4. W. S. Mason, C. Aldrich, J. Summers, and J. M. Taylor, “Asymmetric replication of duck hepatitis B virus DNA in liver cells: free minus-strand DNA,” Proceedings of the National Academy of Sciences of the United States of America, vol. 79, no. 13, pp. 3977–4001, 1982. View at Google Scholar · View at Scopus
  5. D. Ganem, “The X files—one step closer to closure,” Science, vol. 294, no. 5550, pp. 2299–2300, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. A. M. Prince, “An antigen detected in the blood during the incubation period of serum hepatitis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 60, no. 3, pp. 814–821, 1968. View at Google Scholar · View at Scopus
  7. B. S. Blumberg, H. J. Alter, and S. Visnich, “A “New” Antigen in Leukemia Sera,” The Journal of the American Medical Association, vol. 191, pp. 541–546, 1965. View at Google Scholar · View at Scopus
  8. A. J. V. Thompson, T. Nguyen, D. Iser et al., “Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers,” Hepatology, vol. 51, no. 6, pp. 1933–1944, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Gramenzi, E. Loggi, L. Micco et al., “Serum hepatitis B surface antigen monitoring in long-term lamivudine-treated hepatitis B virus patients,” Journal of Viral Hepatitis, vol. 18, no. 10, pp. e468–e474, 2011. View at Publisher · View at Google Scholar
  10. H. L.-Y. Chan, A. Thompson, M. Martinot-Peignoux et al., “Hepatitis B surface antigen quantification: why and how to use it in 2011—a core group report,” Journal of Hepatology, vol. 55, no. 5, pp. 1121–1131, 2011. View at Publisher · View at Google Scholar
  11. M. L. Op den Brouw, R. S. Binda, M. H. van Roosmalen et al., “Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus,” Immunology, vol. 126, no. 2, pp. 280–289, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. R. G. van der Molen, D. Sprengers, R. S. Binda et al., “Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B,” Hepatology, vol. 40, no. 3, pp. 738–746, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Cheng, H. Imanishi, H. Morisaki et al., “Recombinant HBsAg inhibits LPS-induced COX-2 expression and IL-18 production by interfering with the NFκB pathway in a human monocytic cell line, THP-1,” Journal of Hepatology, vol. 43, no. 3, pp. 465–471, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Chen, H. Wei, R. Sun, and Z. Tian, “Impaired function of hepatic natural killer cells from murine chronic HBsAg carriers,” International Immunopharmacology, vol. 5, no. 13-14, pp. 1839–1852, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Vanlandschoot, F. van Houtte, A. Roobrouck, A. Farhoudi, and G. Leroux-Roels, “Hepatitis B virus surface antigen suppresses the activation of monocytes through interaction with a serum protein and a monocyte-specific receptor,” Journal of General Virology, vol. 83, part 6, pp. 1281–1289, 2002. View at Google Scholar · View at Scopus
  16. P. Vanlandschoot, A. Roobrouck, F. van Houtte, and G. Leroux-Roels, “Recombinant HBsAg, an apoptotic-like lipoprotein, interferes with the LPS-induced activation of ERK-1/2 and JNK-1/2 in monocytes,” Biochemical and Biophysical Research Communications, vol. 297, no. 3, pp. 486–491, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Zhou, L. Zheng, L. Liu, L. Xiang, and Z. Yuan, “T helper 2 immunity to hepatitis B surface antigen primed by gene-gun-mediated DNA vaccination can be shifted towards T helper 1 immunity by codelivery of CpG motif-containing oligodeoxynucleotides,” Scandinavian Journal of Immunology, vol. 58, no. 3, pp. 350–357, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Maier, M. Isogawa, G. J. Freeman, and F. V. Chisari, “PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver,” Journal of Immunology, vol. 178, no. 5, pp. 2714–2720, 2007. View at Google Scholar · View at Scopus
  19. T. Kanto, “Virus associated innate immunity in liver,” Frontiers in Bioscience, vol. 13, pp. 6183–6192, 2008. View at Google Scholar · View at Scopus
  20. S. Reignat, G. J. M. Webster, D. Brown et al., “Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection,” Journal of Experimental Medicine, vol. 195, no. 9, pp. 1089–1101, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Roh and K. Kim, “Overcoming tolerance in hepatitis B virus transgenic mice: a possible involvement of regulatory T cells,” Microbiology and Immunology, vol. 47, no. 6, pp. 453–460, 2003. View at Google Scholar · View at Scopus
  22. H. Frebel, K. Richter, and A. Oxenius, “How chronic viral infections impact on antigen-specific T-cell responses,” European Journal of Immunology, vol. 40, no. 3, pp. 654–663, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Kondo, K. Kobayashi, Y. Ueno et al., “Mechanism of T cell hyporesponsiveness to HBcAg is associated with regulatory T cells in chronic hepatitis B,” World Journal of Gastroenterology, vol. 12, no. 27, pp. 4310–4317, 2006. View at Google Scholar · View at Scopus
  24. Y. Kondo, Y. Ueno, K. Kobayashi et al., “Hepatitis B virus replication could enhance regulatory T cell activity by producing soluble heat shock protein 60 from hepatocytes,” Journal of Infectious Diseases, vol. 202, no. 2, pp. 202–213, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Möröy, J. Etiemble, C. Trépo, P. Tiollais, and M. A. Buendia, “Transcription of woodchuck hepatitis virus in the chronically infected liver,” The EMBO Journal, vol. 4, no. 6, pp. 1507–1514, 1985. View at Google Scholar · View at Scopus
  26. S. Tavakoli, I. Mederacke, S. Herzog-Hauff et al., “Peripheral blood dendritic cells are phenotypically and functionally intact in chronic hepatitis B virus (HBV) infection,” Clinical and Experimental Immunology, vol. 151, no. 1, pp. 61–70, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Untergasser, U. Zedler, A. Langenkamp et al., “Dendritic cells take up viral antigens but do not support the early steps of hepatitis B virus infection,” Hepatology, vol. 43, no. 3, pp. 539–547, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Manigold and V. Racanelli, “T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies,” Lancet Infectious Diseases, vol. 7, no. 12, pp. 804–813, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Billerbeck, T. Böttler, and R. Thimme, “Regulatory T cells in viral hepatitis,” World Journal of Gastroenterology, vol. 13, no. 36, pp. 4858–4864, 2007. View at Google Scholar · View at Scopus
  30. A. D. Sette, C. Oseroff, J. Sidney et al., “Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice,” Journal of Immunology, vol. 166, no. 2, pp. 1389–1397, 2001. View at Google Scholar · View at Scopus
  31. W. O. Böcher, E. Galun, H. Marcus et al., “Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the trimera mouse,” Hepatology, vol. 31, no. 2, pp. 480–487, 2000. View at Google Scholar · View at Scopus
  32. L. G. Guidotti, T. Ishikawa, M. V. Hobbs, B. Matzke, R. Schreiber, and F. V. Chisari, “Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes,” Immunity, vol. 4, no. 1, pp. 25–36, 1996. View at Publisher · View at Google Scholar · View at Scopus
  33. F. V. Chisari and C. Ferrari, “Hepatitis B virus immunopathogenesis,” Annual Review of Immunology, vol. 13, pp. 29–60, 1995. View at Google Scholar · View at Scopus
  34. P. T. F. Kennedy, A. J. Gehring, A. Nowbath et al., “The expression and function of NKG2D molecule on intrahepatic CD8+ T cells in chronic viral hepatitis,” Journal of Viral Hepatitis, vol. 15, no. 12, pp. 901–909, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Romagnani, K. Juelke, M. Falco et al., “CD56brightCD16-killer Ig-like receptor-NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation,” Journal of Immunology, vol. 178, no. 8, pp. 4947–4955, 2007. View at Google Scholar · View at Scopus
  36. A. Chan, D. L. Hong, A. Atzberger et al., “CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts,” Journal of Immunology, vol. 179, no. 1, pp. 89–94, 2007. View at Google Scholar · View at Scopus
  37. W. E. Seaman, “Natural killer cells and natural killer T cells,” Arthritis & Rheumatism, vol. 43, no. 6, pp. 1204–1217, 2000. View at Google Scholar
  38. I. Carey, L. D'Antiga, S. Bansal et al., “Immune and viral profile from tolerance to hepatitis B surface antigen clearance: a longitudinal study of vertically hepatitis B virus-infected children on combined therapy,” Journal of Virology, vol. 85, no. 5, pp. 2416–2428, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. D. R. Langley, A. W. Walsh, C. J. Baldick et al., “Inhibition of hepatitis B virus polymerase by entecavir,” Journal of Virology, vol. 81, no. 8, pp. 3992–4001, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. M. J. Tong and S. S. Tu, “Treatment of patients with chronic hepatitis B with adefovir dipivoxil,” Seminars in Liver Disease, vol. 24, supplement 1, pp. 37–44, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Guan, “Interferon monotherapy in chronic hepatitis B,” Journal of Gastroenterology and Hepatology, vol. 15, pp. E34–E40, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Pol and M. L. Michel, “Therapeutic vaccination in chronic hepatitis B virus carriers,” Expert Review of Vaccines, vol. 5, no. 5, pp. 707–716, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Kondo, Y. Ueno, and T. Shimosegawa, “Immunopathogenesis of hepatitis B persistent infection: Implications for immunotherapeutic strategies,” Clinical Journal of Gastroenterology, vol. 2, no. 2, pp. 71–79, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. F. Rahman, A. Dahmen, S. Herzog-Hauff, W. O. Böcher, P. R. Galle, and H. E. Löhr, “Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen,” Hepatology, vol. 31, no. 2, pp. 521–527, 2000. View at Google Scholar · View at Scopus
  45. H. Y. Hsu, M. H. Chang, R. P. Hsieh, Y. H. Ni, and W. K. Chi, “Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen,” Hepatology, vol. 24, no. 6, pp. 1355–1360, 1996. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Kondo, S. Asabe, K. Kobayashi et al., “Recovery of functional cytotoxic T lymphocytes during lamivudine therapy by acquiring multi-specificity,” Journal of Medical Virology, vol. 74, no. 3, pp. 425–433, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. Kondo, K. Kobayashi, S. Asabe et al., “Vigorous response of cytotoxic T lymphocytes associated with systemic activation of CD8+ T lymphocytes in fulminant hepatitis B,” Liver International, vol. 24, no. 6, pp. 561–567, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. R. Nayersina, P. Fowler, S. Guilhot et al., “HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection,” Journal of Immunology, vol. 150, no. 10, pp. 4659–4671, 1993. View at Google Scholar · View at Scopus
  49. B. Rehermann and M. Nascimbeni, “Immunology of hepatitis B virus and hepatitis C virus infection,” Nature Reviews Immunology, vol. 5, no. 3, pp. 215–229, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. B. J. McMahon, “The natural history of chronic hepatitis B virus infection,” Hepatology, vol. 49, supplement 5, pp. S45–S55, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. B. J. McMahon, “The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B,” Hepatology International, vol. 3, no. 2, pp. 334–342, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. C. Grégoire, L. Chasson, C. Luci et al., “The trafficking of natural killer cells,” Immunological Reviews, vol. 220, no. 1, pp. 169–182, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. D. G. Doherty and C. O'Farrelly, “Innate and adaptive lymphoid cells in the human liver,” Immunological Reviews, vol. 174, pp. 5–20, 2000. View at Publisher · View at Google Scholar · View at Scopus
  54. M. J. Loza, L. Zamai, L. Azzoni, E. Rosati, and B. Perussia, “Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells,” Blood, vol. 99, no. 4, pp. 1273–1281, 2002. View at Publisher · View at Google Scholar · View at Scopus
  55. M. A. Cooper, T. A. Fehniger, S. C. Turner et al., “Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset,” Blood, vol. 97, no. 10, pp. 3146–3151, 2001. View at Publisher · View at Google Scholar · View at Scopus
  56. J. D. Gray, M. Hirokawa, K. Ohtsuka, and D. A. Horwitz, “Generation of an inhibitory circuit involving CD8+ T cells, IL-2, and NK cell-derived TGF-β: Contrasting effects of anti-CD2 and anti-CD3,” Journal of Immunology, vol. 160, no. 5, pp. 2248–2254, 1998. View at Google Scholar · View at Scopus
  57. S. Porcelli, C. E. Yockey, M. B. Brenner, and S. P. Balk, “Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- α/β T cells demonstrates preferential use of several Vβ genes and an invariant TCR α chain,” Journal of Experimental Medicine, vol. 178, no. 1, pp. 1–16, 1993. View at Google Scholar · View at Scopus
  58. C. H. Kim, B. Johnston, and E. C. Butcher, “Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among Vα24+Vβ11+ NKT cell subsets with distinct cytokine-producing capacity,” Blood, vol. 100, no. 1, pp. 11–16, 2002. View at Publisher · View at Google Scholar · View at Scopus
  59. B. Albarran, L. Goncalves, S. Salmen et al., “Profiles of NK, NKT cell activation and cytokine production following vaccination against hepatitis B,” APMIS, vol. 113, no. 7-8, pp. 526–535, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. A. M. Woltman mail, M. L. Op den Brouw, P. J. Biesta, and C. C. Shi, “Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function,” PLOS One, vol. 6, no. 1, Article ID e15324, 2011. View at Publisher · View at Google Scholar
  61. F. Imazeki, M. Omata, O. Yokosuka, and K. Okuda, “Integration of hepatitis B virus DNA in hepatocellular carcinoma,” Cancer, vol. 58, no. 5, pp. 1055–1060, 1986. View at Google Scholar · View at Scopus
  62. K. Koike, T. Tsutsumi, H. Fujie, Y. Shintani, and K. Moriya, “Molecular mechanism of viral hepatocarcinogenesis,” Oncology, vol. 62, supplement 1, pp. 29–37, 2002. View at Publisher · View at Google Scholar · View at Scopus
  63. F. Staib, S. P. Hussain, L. J. Hofseth, X. W. Wang, and C. C. Harris, “TP53 and liver carcinogenesis,” Human Mutation, vol. 21, no. 3, pp. 201–216, 2003. View at Publisher · View at Google Scholar · View at Scopus
  64. D. Cougot, C. Neuveut, and M. A. Buendia, “HBV-induced carcinogenesis,” Journal of Clinical Virology, vol. 34, supplement 1, pp. S75–S78, 2005. View at Publisher · View at Google Scholar · View at Scopus
  65. H. L. Y. Chan and J. J. Y. Sung, “Hepatocellular carcinoma and hepatitis B virus,” Seminars in Liver Disease, vol. 26, no. 2, pp. 153–161, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. A. S. Kekule, U. Lauer, M. Meyer, W. H. Caselmann, P. H. Hofschneider, and R. Koshy, “The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator,” Nature, vol. 343, no. 6257, pp. 457–461, 1990. View at Publisher · View at Google Scholar · View at Scopus
  67. J. H. Hung, I. J. Su, H. Y. Lei et al., “Endoplasmic reticulum stress stimulates the expression of cyclooxygenase-2 through activation of NF-κB and pp38 mitogen-activated protein kinase,” Journal of Biological Chemistry, vol. 279, no. 45, pp. 46384–46392, 2004. View at Publisher · View at Google Scholar · View at Scopus
  68. H. C. Wang, H. C. Wu, C. F. Chen, N. Fausto, H. Y. Lei, and I. J. Su, “Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress,” American Journal of Pathology, vol. 163, no. 6, pp. 2441–2449, 2003. View at Google Scholar · View at Scopus
  69. H. Kadowaki, H. Nishitoh, and H. Ichijo, “Survival and apoptosis signals in ER stress: the role of protein kinases,” Journal of Chemical Neuroanatomy, vol. 28, no. 1-2, pp. 93–100, 2004. View at Publisher · View at Google Scholar · View at Scopus
  70. M. M. Hassan, L. Y. Hwang, C. J. Hatten et al., “Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus,” Hepatology, vol. 36, no. 5, pp. 1206–1213, 2002. View at Publisher · View at Google Scholar · View at Scopus
  71. H. I. Yang, S. N. Lu, Y. F. Liaw et al., “.Hepatitis B e antigen and the risk of hepatocellular carcinoma,” The New England Journal of Medicine, vol. 347, no. 3, pp. 168–174, 2002. View at Publisher · View at Google Scholar
  72. H. C. Wang, W. Huang, M. D. Lai, and I. J. Su, “Hepatitis B Virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis,” Cancer Science, vol. 97, no. 8, pp. 683–688, 2006. View at Publisher · View at Google Scholar · View at Scopus
  73. W. Ke, I. Kryczek, L. Chen, W. Zou, and T. H. Welling, “Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions,” Cancer Research, vol. 69, no. 20, pp. 8067–8075, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. K. Matsuzaki, M. Date, F. Furukawa et al., “Regulatory mechanisms for transforming growth factor β as an autocrine inhibitor in human hepatocellular carcinoma: implications for roles of smads in its growth,” Hepatology, vol. 32, no. 2, pp. 218–227, 2000. View at Google Scholar · View at Scopus
  75. K. J. Chen, S. Z. Lin, L. Zhou et al., “Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis,” PLoS One, vol. 6, no. 9, Article ID e24671, 2011. View at Google Scholar
  76. W. C. Lee, T. J. Wu, H. S. Chou et al., “The impact of CD4+CD25+ T cells in the tumor microenvironment of hepatocellular carcinoma,” Surgery, vol. 151, no. 2, pp. 213–222, 2012. View at Google Scholar
  77. K. J. Chen, L. Zhou, H. Y. Xie, T. E. Ahmed, X. W. Feng, and S. S. Zheng, “Intratumoral regulatory T cells alone or in combination with cytotoxic T cells predict prognosis of hepatocellular carcinoma after resection,” Medical Oncology, vol. 29, no. 3, pp. 1817–1826, 2012. View at Publisher · View at Google Scholar · View at Scopus
  78. Y. Takata, Y. Nakamoto, A. Nakada et al., “Frequency of CD45RO+ subset in CD4+CD25high regulatory T cells associated with progression of hepatocellular carcinoma,” Cancer Letters, vol. 307, no. 2, pp. 165–173, 2011. View at Publisher · View at Google Scholar · View at Scopus
  79. R. Cabrera, M. Ararat, E. A. Eksioglu et al., “Influence of serum and soluble CD25 (sCD25) on regulatory and effector T-cell function in hepatocellular carcinoma,” Scandinavian Journal of Immunology, vol. 72, no. 4, pp. 293–301, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. Q. Gao, X. Y. Wang, S. J. Qiu et al., “Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma,” Clinical Cancer Research, vol. 15, no. 3, pp. 971–979, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. B. Hoechst, L. A. Ormandy, M. Ballmaier et al., “A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4+CD25+Foxp3+ T cells,” Gastroenterology, vol. 135, no. 1, pp. 234–243, 2008. View at Publisher · View at Google Scholar
  82. C. Miroux, T. Vausselin, and N. Delhem, “Regulatory T cells in HBV and HCV liver diseases: implication of regulatory T lymphocytes in the control of immune response,” Expert Opinion on Biological Therapy, vol. 10, no. 11, pp. 1563–1572, 2010. View at Publisher · View at Google Scholar · View at Scopus
  83. K. Shirabe, T. Motomura, J. Muto et al., “Tumor-infiltrating lymphocytes and hepatocellular carcinoma: pathology and clinical management,” International Journal of Clinical Oncology, vol. 15, no. 6, pp. 552–558, 2010. View at Publisher · View at Google Scholar · View at Scopus
  84. Z. Q. Yang, Z. Y. Yang, L. D. Zhang et al., “Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients,” Human Immunology, vol. 71, no. 12, pp. 1180–1186, 2010. View at Publisher · View at Google Scholar · View at Scopus
  85. X. Shen, N. Li, H. Li, T. Zhang, F. Wang, and Q. Li, “Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma,” Journal of Cancer Research and Clinical Oncology, vol. 136, no. 11, pp. 1745–1754, 2010. View at Publisher · View at Google Scholar · View at Scopus
  86. J. Fu, D. Xu, Z. Liu et al., “Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients,” Gastroenterology, vol. 132, no. 7, pp. 2328–2339, 2007. View at Publisher · View at Google Scholar · View at Scopus
  87. M. Yamamoto, T. Tatsumi, T. Miyagi et al., “α-Fetoprotein impairs activation of natural killer cells by inhibiting the function of dendritic cells,” Clinical and Experimental Immunology, vol. 165, no. 2, pp. 211–219, 2011. View at Publisher · View at Google Scholar · View at Scopus
  88. C. Zhou, G. Peng, X. Jin, J. Tang, and Z. Chen, “Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine,” Clinical Immunology, vol. 137, no. 2, pp. 190–198, 2010. View at Publisher · View at Google Scholar · View at Scopus
  89. A. Memarnejadian and F. Roohvand, “Fusion of HBsAg and prime/boosting augment Th1 and CTL responses to HCV polytope DNA vaccine,” Cellular Immunology, vol. 261, no. 2, pp. 93–98, 2010. View at Publisher · View at Google Scholar · View at Scopus
  90. K. Yang, B. J. Whalen, R. S. Tirabassi et al., “A DNA vaccine prime followed by a liposome-encapsulated protein boost confers enhanced mucosal immune responses and protection,” Journal of Immunology, vol. 180, no. 9, pp. 6159–6167, 2008. View at Google Scholar · View at Scopus
  91. S. Menne, B. C. Tennant, J. L. Gerin, and P. J. Cote, “Chemoimmunotherapy of chronic hepatitis B virus infection in the woodchuck model overcomes immunologic tolerance and restores T-cell responses to pre-S and S regions of the viral envelope protein,” Journal of Virology, vol. 81, no. 19, pp. 10614–10624, 2007. View at Publisher · View at Google Scholar · View at Scopus
  92. E. Iglesias, R. Thompson, Y. Carrazana et al., “Coinoculation with hepatitis B surface and core antigen promotes a Th1 immune response to a multiepitopic protein of HIV-1,” Immunology and Cell Biology, vol. 84, no. 2, pp. 174–183, 2006. View at Publisher · View at Google Scholar · View at Scopus
  93. S. J. Qiu, L. Lu, C. Qiao et al., “Induction of tumor immunity and cytotoxic t lymphocyte responses using dendritic cells transduced by adenoviral vectors encoding HBsAg: comparison to protein immunization,” Journal of Cancer Research and Clinical Oncology, vol. 131, no. 7, pp. 429–438, 2005. View at Publisher · View at Google Scholar · View at Scopus
  94. L. Zhang, G. Widera, S. Bleecher, D. A. Zaharoff, B. Mossop, and D. Rabussay, “Accelerated immune response to DNA vaccines,” DNA and Cell Biology, vol. 22, no. 12, pp. 815–822, 2003. View at Publisher · View at Google Scholar · View at Scopus
  95. M. L. Michel and M. Mancini-Bourgine, “Therapeutic vaccination against chronic hepatitis B virus infection,” Journal of Clinical Virology, vol. 34, supplement 1, pp. S108–S114, 2005. View at Publisher · View at Google Scholar · View at Scopus
  96. Y. M. Wen, X. H. Wu, D. C. Hu, Q. P. Zhang, and S. Q. Guo, “Hepatitis B vaccine and anti-HBs complex as approach for vaccine therapy,” The Lancet, vol. 345, no. 8964, pp. 1575–1576, 1995. View at Google Scholar · View at Scopus
  97. S. M. F. Akbar, N. Horiike, S. Chen et al., “Mechanism of restoration of immune responses of patients with chronic hepatitis B during lamivudine therapy: increased antigen processing and presentation by dendritic cells,” Journal of Viral Hepatitis, vol. 18, no. 3, pp. 200–205, 2011. View at Publisher · View at Google Scholar · View at Scopus